4
Changes in Ownership
Larimar Therapeutics, Inc. Filed Acc 0001209191-15-021905
Options or other derivatives
- Chief Commercial Officer acquired 60,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Secor Alicia · Chief Commercial Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2015-02-27 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +60,000 | $38.65 | 2025-02-27 | 60,000 | 219,235 | D |
Loading xslF345X03/doc4.xml…